Integrins in mammary development

Seminars in Cell and Developmental Biology

Volumn 23, Issue 5, 2012, Pages 599-605

  Raymond, Karine ^a,b   Faraldo, Marisa M ^a,b   Deugnier, Marie Ange ^a,b   Glukhova, Marina A ^a,b  

^a INSTITUT CURIE   (France)

^b CNRS   (France)

Author keywords

Adhesion; Differentiation; Extracellular matrix; Intracellular signaling; Morphogenesis; Stem cells

Indexed keywords

ALPHA1 INTEGRIN; ALPHA2 INTEGRIN; ALPHA3 INTEGRIN; ALPHA6 INTEGRIN; BETA1 INTEGRIN; BETA4 INTEGRIN; FIBRONECTIN; FOCAL ADHESION KINASE; INTEGRIN; INTEGRIN LINKED KINASE;

BREAST CANCER; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; BREAST EPITHELIUM; CELL DIFFERENTIATION; CELL MOTILITY; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; INTRACELLULAR SIGNALING; MORPHOGENESIS; NONHUMAN; PROTEIN EXPRESSION; REVIEW; STEM CELL;

EID: 84863868389     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2012.03.008     Document Type: Review

References (62)

1. Kendrick H., Regan J.L., Magnay F.A., Grigoriadis A., Mitsopoulos C., Zvelebil M., et al. Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate. BMC Genomics 2008, 9:591.
2. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
3. Barczyk M., Carracedo S., Gullberg D. Integrins. Cell Tissue Res 2011, 339:269-280.
4. DuFort C.C., Paszek M.J., Weaver V.M. Balancing forces: architectural control of mechanotransduction. Nat Rev Mol Cell Biol 2011, 12:308-319.
5. Streuli C.H., Akhtar N. Signal co-operation between integrins and other receptor systems. Biochem J 2009, 418:491-506.
6. Cabodi S., del Pilar Camacho-Leal M., Di Stefano P., Defilippi P. Integrin signalling adaptors: not only figurants in the cancer story. Nat Rev Cancer 2010, 10:858-870.
7. Taddei I., Faraldo M.M., Teuliere J., Deugnier M.A., Thiery J.P., Glukhova M.A. Integrins in mammary gland development and differentiation of mammary epithelium. J Mammary Gland Biol Neoplasia 2003, 8:383-394.
8. Stingl J., Eirew P., Ricketson I., Shackleton M., Vaillant F., Choi D., et al. Purification and unique properties of mammary epithelial stem cells. Nature 2006, 439:993-997.
9. Shackleton M., Vaillant F., Simpson K.J., Stingl J., Smyth G.K., Asselin-Labat M.L., et al. Generation of a functional mammary gland from a single stem cell. Nature 2006, 439:84-88.
10. Asselin-Labat M.L., Sutherland K.D., Barker H., Thomas R., Shackleton M., Forrest N.C., et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 2007, 9:201-209.
11. Li W., Ferguson B.J., Khaled W.T., Tevendale M., Stingl J., Poli V., et al. PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool. Proc Natl Acad Sci USA 2009, 106:4725-4730.
12. Hirai Y., Nelson C.M., Yamazaki K., Takebe K., Przybylo J., Madden B., et al. Non-classical export of epimorphin and its adhesion to alphav-integrin in regulation of epithelial morphogenesis. J Cell Sci 2007, 120:2032-2043.
13. Ensslin M.A., Shur B.D. The EGF repeat and discoidin domain protein, SED1/MFG-E8, is required for mammary gland branching morphogenesis. Proc Natl Acad Sci USA 2007, 104:2715-2720.
14. Haslam S.Z., Woodward T.L. Reciprocal regulation of extracellular matrix proteins and ovarian steroid activity in the mammary gland. Breast Cancer Res 2001, 3:365-372.
15. Carroll D.K., Carroll J.S., Leong C.O., Cheng F., Brown M., Mills A.A., et al. p63 regulates an adhesion programme and cell survival in epithelial cells. Nat Cell Biol 2006, 8:551-561.
16. Yang X., Pursell B., Lu S., Chang T.K., Mercurio A.M. Regulation of beta 4-integrin expression by epigenetic modifications in the mammary gland and during the epithelial-to-mesenchymal transition. J Cell Sci 2009, 122:2473-2480.
17. Li N., Zhang Y., Naylor M.J., Schatzmann F., Maurer F., Wintermantel T., et al. Beta1 integrins regulate mammary gland proliferation and maintain the integrity of mammary alveoli. EMBO J 2005, 24:1942-1953.
18. Naylor M.J., Li N., Cheung J., Lowe E.T., Lambert E., Marlow R., et al. Ablation of beta1 integrin in mammary epithelium reveals a key role for integrin in glandular morphogenesis and differentiation. J Cell Biol 2005, 171:717-728.
19. Akhtar N., Marlow R., Lambert E., Schatzmann F., Lowe E.T., Cheung J., et al. Molecular dissection of integrin signalling proteins in the control of mammary epithelial development and differentiation. Development 2009, 136:1019-1027.
20. Nagy T., Wei H., Shen T.L., Peng X., Liang C.C., Gan B., et al. Mammary epithelial-specific deletion of the focal adhesion kinase gene leads to severe lobulo-alveolar hypoplasia and secretory immaturity of the murine mammary gland. J Biol Chem 2007, 282:31766-31776.
21. Wagner K.U., McAllister K., Ward T., Davis B., Wiseman R., Hennighausen L. Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice. Transgenic Res 2001, 10:545-553.
22. Taddei I., Deugnier M.A., Faraldo M.M., Petit V., Bouvard D., Medina D., et al. Beta1 integrin deletion from the basal compartment of the mammary epithelium affects stem cells. Nat Cell Biol 2008, 10:716-722.
23. Raymond K., Cagnet S., Kreft M., Janssen H., Sonnenberg A., Glukhova M.A. Control of mammary myoepithelial cell contractile function by alpha3beta1 integrin signalling. EMBO J 2011, 30:1896-1906.
24. Woodward T.L., Mienaltowski A.S., Modi R.R., Bennett J.M., Haslam S.Z. Fibronectin and the alpha(5)beta(1) integrin are under developmental and ovarian steroid regulation in the normal mouse mammary gland. Endocrinology 2001, 142:3214-3222.
25. Liu K., Cheng L., Flesken-Nikitin A., Huang L., Nikitin A.Y., Pauli B.U. Conditional knockout of fibronectin abrogates mouse mammary gland lobuloalveolar differentiation. Dev Biol 2010, 346:11-24.
26. Pepper M.S., Baetens D., Mandriota S.J., Di Sanza C., Oikemus S., Lane T.F., et al. Regulation of VEGF and VEGF receptor expression in the rodent mammary gland during pregnancy, lactation, and involution. Dev Dyn 2000, 218:507-524.
27. Williams C.M., Engler A.J., Slone R.D., Galante L.L., Schwarzbauer J.E. Fibronectin expression modulates mammary epithelial cell proliferation during acinar differentiation. Cancer Res 2008, 68:3185-3192.
28. Hennighausen L., Robinson G.W. Information networks in the mammary gland. Nat Rev Mol Cell Biol 2005, 6:715-725.
29. Muschler J., Streuli C.H. Cell-matrix interactions in mammary gland development and breast cancer. Cold Spring Harb Perspect Biol 2010, 2:a003202.
30. Faraldo M.M., Deugnier M.A., Tlouzeau S., Thiery J.P., Glukhova M.A. Perturbation of beta1-integrin function in involuting mammary gland results in premature dedifferentiation of secretory epithelial cells. Mol Biol Cell 2002, 13:3521-3531.
31. Xu R., Nelson C.M., Muschler J.L., Veiseh M., Vonderhaar B.K., Bissell M.J. Sustained activation of STAT5 is essential for chromatin remodeling and maintenance of mammary-specific function. J Cell Biol 2009, 184:57-66.
32. Xu R., Spencer V.A., Groesser D.L., Bissell M.J. Laminin regulates PI3K basal localization and activation to sustain STAT5 activation. Cell Cycle 2010, 9:4315-4322.
33. Akhtar N., Streuli C.H. Rac1 links integrin-mediated adhesion to the control of lactational differentiation in mammary epithelia. J Cell Biol 2006, 173:781-793.
34. LaBarge M.A., Nelson C.M., Villadsen R., Fridriksdottir A., Ruth J.R., Stampfer M.R., et al. Human mammary progenitor cell fate decisions are products of interactions with combinatorial microenvironments. Integr Biol (Camb) 2009, 1:70-79.
35. Bachelard-Cascales E., Chapellier M., Delay E., Pochon G., Voeltzel T., Puisieux A., et al. The CD10 enzyme is a key player to identify and regulate human mammary stem cells. Stem Cells 2010, 28:1081-1088.
36. Deugnier M.A., Faraldo M.M., Teuliere J., Thiery J.P., Medina D., Glukhova M.A. Isolation of mouse mammary epithelial progenitor cells with basal characteristics from the Comma-Dbeta cell line. Dev Biol 2006, 293:414-425.
37. Sleeman K.E., Kendrick H., Robertson D., Isacke C.M., Ashworth A., Smalley M.J. Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland. J Cell Biol 2007, 176:19-26.
38. Visvader J.E. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev 2009, 23:2563-2577.
39. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003, 100:3983-3988.
40. Vaillant F., Asselin-Labat M.L., Shackleton M., Forrest N.C., Lindeman G.J., Visvader J.E. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Res 2008, 68:7711-7717.
41. Zhang M., Behbod F., Atkinson R.L., Landis M.D., Kittrell F., Edwards D., et al. Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res 2008, 68:4674-4682.
42. Rathinam R., Alahari S.K. Important role of integrins in the cancer biology. Cancer Metastasis Rev 2010, 29:223-237.
43. Guan J.L. Integrin signaling through FAK in the regulation of mammary stem cells and breast cancer. IUBMB Life 2010, 62:268-276.
44. Howe E.N., Cochrane D.R., Richer J.K. Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Res 2011, 13:R45.
45. Iliopoulos D., Polytarchou C., Hatziapostolou M., Kottakis F., Maroulakou I.G., Struhl K., et al. MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells. Sci Signal 2009, 2:ra62.
46. Iliopoulos D., Lindahl-Allen M., Polytarchou C., Hirsch H.A., Tsichlis P.N., Struhl K. Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells. Mol Cell 2010, 39:761-772.
47. Provenzano P.P., Inman D.R., Eliceiri K.W., Keely P.J. Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage. Oncogene 2009, 28:4326-4343.
48. Ilic D., Almeida E.A., Schlaepfer D.D., Dazin P., Aizawa S., Damsky C.H. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J Cell Biol 1998, 143:547-560.
49. Lim S.T., Chen X.L., Lim Y., Hanson D.A., Vo T.T., Howerton K., et al. Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. Mol Cell 2008, 29:9-22.
50. White D.E., Cardiff R.D., Dedhar S., Muller W.J. Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice. Oncogene 2001, 20:7064-7072.
51. Oloumi A., Maidan M., Lock F.E., Tearle H., McKinney S., Muller W.J., et al. Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development. Breast Cancer Res 2010, 12:R38.
52. Marcotte R., Smith H.W., Sanguin-Gendreau V., McDonough R.V., Muller W.J. Mammary epithelial-specific disruption of c-Src impairs cell cycle progression and tumorigenesis. Proc Natl Acad Sci USA 2011, 10.1073/pnas.1018861108.
53. White D.E., Kurpios N.A., Zuo D., Hassell J.A., Blaess S., Mueller U., et al. Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell 2004, 6:159-170.
54. Lahlou H., Sanguin-Gendreau V., Zuo D., Cardiff R.D., McLean G.W., Frame M.C., et al. Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression. Proc Natl Acad Sci USA 2007, 104:20302-20307.
55. Provenzano P.P., Inman D.R., Eliceiri K.W., Beggs H.E., Keely P.J. Mammary epithelial-specific disruption of focal adhesion kinase retards tumor formation and metastasis in a transgenic mouse model of human breast cancer. Am J Pathol 2008, 173:1551-1565.
56. Pylayeva Y., Gillen K.M., Gerald W., Beggs H.E., Reichardt L.F., Giancotti F.G. Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J Clin Invest 2009, 119:252-266.
57. Luo M., Fan H., Nagy T., Wei H., Wang C., Liu S., et al. Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells. Cancer Res 2009, 69:466-474.
58. Ramirez N.E., Zhang Z., Madamanchi A., Boyd K.L., O'Rear L.D., Nashabi A., et al. The alphabeta integrin is a metastasis suppressor in mouse models and human cancer. J Clin Invest 2011, 121:226-237.
59. Guo W., Pylayeva Y., Pepe A., Yoshioka T., Muller W.J., Inghirami G., et al. Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 2006, 126:489-502.
60. Huck L., Pontier S.M., Zuo D.M., Muller W.J. beta1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression. Proc Natl Acad Sci USA 2010, 107:15559-15564.
61. Pontier S.M., Huck L., White D.E., Rayment J., Sanguin-Gendreau V., Hennessy B., et al. Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer. Oncogene 2010, 29:3374-3385.
62. Cabodi S., Tinnirello A., Di Stefano P., Bisaro B., Ambrosino E., Castellano I., et al. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cancer Res 2006, 66:4672-4680.